Stocks · News reference
Coloplast (OTC:CLPBY) affirms FY2026 sales outlook from $4.499 billion to $4.499 billion vs $4.420 billion estimate.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Coloplast (OTC:CLPBY) released third-quarter financial results and hosted an earnings call on Tuesday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and
Coloplast (OTC:CLPBY) reported quarterly earnings of $0.10 per share which met the analyst consensus estimate. This is a 66.67 percent increase over earnings of $0.06 per share from the same period last year. The